Discovery of N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides as DNA gyrase B-targeted antibacterial agents

Wenjie Xue, Yaling Wang, Xu Lian, Xueyao Li, Jing Pang, Johannes Kirchmair, Kebin Wu, Zunsheng Han, Xuefu You, Hongmin Zhang, Jie Xia, Song Wu

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)1620-1631
Number of pages12
JournalJournal of Enzyme Inhibition and Medicinal Chemistry
Volume37
Issue number1
DOIs
Publication statusPublished - 31 Dec 2022

Funding

This work was supported by the CAMS Innovation Fund for Medical Sciences [Grant No. 2021-I2M-1-069], Fundamental Research Program of Shanxi Province [Grant No. 20210302124300], the Shanxi Bethune Hospital Scientific Research Fund for Talent Recruitment [Grant No. 2021RC008], "Universities and Colleges Key Programs for Foreign Talent" of State Administration of Foreign Experts Affairs P.R. China [Grant No. T2018042].

Austrian Fields of Science 2012

  • 106005 Bioinformatics
  • 301207 Pharmaceutical chemistry

Keywords

  • Antibiotic resistance
  • MRSA
  • antibacterial agent
  • DNA Gyrase inhibitors
  • computer-aided drug design
  • ATPASE INHIBITORS
  • TOPOISOMERASE

Fingerprint

Dive into the research topics of 'Discovery of N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides as DNA gyrase B-targeted antibacterial agents'. Together they form a unique fingerprint.

Cite this